Apollomics Inc.
APLMW- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001944885
In the last 90 days, Apollomics Inc. insiders filed 3 open-market purchases and 0 sales; 14 institutions reported holding it in 13F filings for Q2 2026, worth $53.6K in total; no superinvestor holds it.
Other share classesAPLM
Q2 2025 vs. Q1 2025
How the institutions holding Apollomics Inc. changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 19 | 16 | −3 |
| Shares | 4.08M | 3.69M | −392.6K (−9.6%) |
| Value | $34.1K | $146.8K | +$112.7K (+330.8%) |
New holders (1)
Institutions that held Apollomics Inc. at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 328,969 | $14.6K | 0.00% |
Sold out (4)
Institutions that held Apollomics Inc. at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Yakira Capital Management, Inc. | 362,364 | $3.39K |
| Periscope Capital Inc. | 93,700 | $871 |
| Schonfeld Strategic Advisors LLC | 15,000 | $140 |
| Bank of America Corp | 200 | $1 |